Dendritic cells (DCs) are considered the most potent antigen-presenting cells (APCs), which directly prime or cross-prime MHC I-restricted cytotoxic T cells (CTLs). However, recent evidence suggests the existence of other, as-yet unidentified APCs also able to prime T cells. To identify those APCs, we used adenoviral (rAd) vectors, which do not infect DCs but selectively accumulate in CD169 + macrophages (MPs). In mice that lack DCs, infection of CD169 + MPs was sufficient to prime CTLs specific for all epitopes tested. In contrast, CTL responses relying exclusively on cross-presenting DCs were biased to selected strong MHC I-binding peptides only. When both DCs and MPs were absent, no CTL responses could be elicited. Therefore, CD169
Dendritic cells (DCs) are considered the most potent antigen-presenting cells (APCs), which directly prime or cross-prime MHC I-restricted cytotoxic T cells (CTLs). However, recent evidence suggests the existence of other, as-yet unidentified APCs also able to prime T cells. To identify those APCs, we used adenoviral (rAd) vectors, which do not infect DCs but selectively accumulate in CD169 + macrophages (MPs). In mice that lack DCs, infection of CD169 + MPs was sufficient to prime CTLs specific for all epitopes tested. In contrast, CTL responses relying exclusively on cross-presenting DCs were biased to selected strong MHC I-binding peptides only. When both DCs and MPs were absent, no CTL responses could be elicited. Therefore, CD169
+ MPs can be considered APCs that significantly contribute to CTL responses.
CD169
+ macrophage | dendritic cell | cross-presentation | CD8 T cell | adenovirus D endritic cells (DCs) are known to have superior T-cell activation ability compared with other cell types and thus are considered the most potent antigen-presenting cells (APCs) (1) . Experiments with mice lacking DCs have supported this view in many infection and immunization studies (2, 3) . In addition, DCs are specialized to efficiently cross-present exogenous antigen (Ag) via MHC I to CD8 + T cells (4) . In contrast, MPs are considered cells of the innate immune system that limit pathogen spread by phagocytosis and degradation. They are positioned at strategically important entry points, such as the subcapsular sinus of lymph nodes and the marginal zone and red pulp areas of the spleen, where they capture and filter pathogens (5) . Along with producing type I IFN (6), CD169
+ marginal zone metallophilic MPs allow restricted replication of captured virus to increase the local availability of viral Ag (7) for transfer to B cells for humoral responses (8) and to DCs for cross-priming of CD8 + T cells (9) . Participation of MPs in T-cell priming is thought to be restricted to Ag acquisition, amplification, and redistribution.
Analyzing MP functions in vivo is difficult; genetic models, such as the CD11c-diphteria toxin (DT) receptor (DTR) transgenic mice (2) , cannot make the distinction, because both DCs and monocytes/MPs are equally deleted on DT treatment (10, 11) . Recent results with mice lacking CD169 + MPs suggest the role of these MPs in cross-priming of CD8 + T cells specific for the cell-associated model Ag ovalbumin (OVA) in lymph nodes (12) . These findings are in contrast with another study in which MPs were unable to cross-present soluble OVA protein in mice lacking DCs (11) . Although cross-presentation by DCs is now thought to allow priming of cytotoxic T-cell responses to exogenous tumor or viral Ag (4), the importance of cross-presentation in vivo has been a matter of intense debate over the last decade (13) . Although this debate remains unresolved, cross-presentation has been considered then and now to be an exception rather than a rule (14, 15) .
To determine the roles of MPs and DCs, we used a mouse model that specifically lacks DCs but conserves all subpopulations of MPs. We show that the presence of directly infected CD169 + MPs is sufficient to prime CTLs, including those recognizing epitopes not covered by cross-presenting DCs. In contrast, when only DCs cross-prime CTLs without the participation of MPs, the CTL repertoire is incomplete and biased toward the few peptides that interact strongly with MHCI. Our data demonstrate a division of labor between CD169
+ MPs and DCs in situations where CD169
+
MPs sequester the majority of Ag in the marginal zone. In these situations, bystander DCs have to rely on cross-presentation, which elicits CTLs of limited specificity.
Results

Adenoviral Targeting of CD169
+ MPs. To dissect the relative contributions of DCs and MPs to CTL priming, we compared a mouse line that lacks DCs only in secondary lymphoid organs with a mouse line that lacks both DCs and MPs in those organs. As described previously, Δ-DC mice constitutively express diphtheria toxin α-chain (DTA) under control of a loxP-flanked stop cassette in the ROSA26 locus, which is removed on breeding to CD11c-Cre mice, leading to DTA-mediated ablation of conventional DCs and plasmacytoid DCs (3). As a consequence, Δ-DC mice lack DCs, but harbor regular MPs, such as marginal zone SIGN-R1 + and CD169 + MPs, and red pulp F4/80 + MPs of the spleen (3) (Fig. 1A) . In contrast, CD11c-DTR mice express the receptor for DTA constitutively on all CD11c
+ cells and, on DTA treatment, lack CD11c + DCs and all types of MPs in the spleen, as described previously (10, 11) (Fig. 1A) . Subcapsular CD169
+ MPs were present in the lymph nodes of Δ-DC mice, whereas CD11c
+
DCs and CD11c
+
CD169
+ DCs were not, but all cell types were
Significance
Although we know much about the molecular mechanisms of cross-presentation, its actual contribution to cytotoxic T cell (CTL) immunity under physiological conditions in vivo is still unclear. Cross-presentation is based on the idea that dendritic cells (DCs) are the only professional antigen-presenting cells able to prime naïve T cells. If DCs are not directly infected, they must take up antigen and present it indirectly. However, recent evidence suggests that other cells also may be involved in T cell priming, which probably makes cross-presentation less central. This study shows that cross-priming DCs generate highly restricted CTL repertoires, biased to strong MHC I binding epitopes only. Furthermore, the presence of antigen in CD169 + macrophages is sufficient for generation of CTLs with broader repertoires.
missing in CD11c-DTR mice (Fig. S1A) . Thus, these two mouse lines are differentially deprived of APC subsets that are key to pathogen handling and Ag presentation.
To assess the CTL-priming capacities of MPs and DCs without the confounding effects of viral spread and pathogenicity, we injected C57BL/6 (B6) mice with GFP-expressing recombinant adenovirus particles (rAd-GFP) that are unable to replicate. Histological analyses showed that these particles are selectively trapped by marginal zone CD169 + MPs but not by CD11c + DCs or any other cells of the spleen (Fig. 1B) , just as described previously for WT adenovirus (9, 16) . Both CD169 + and SIGN-R1 + MPs of the marginal zone expressed rAd-encoded GFP (Fig. 1B,  Lower) . Importantly, spleens of Δ-DC mice showed the same distribution of rAd-directed GFP expression as WT mice, and both CD169 + and SIGN-R1 + MPs, but no other cells, expressed GFP (Fig. 1C) . The analysis of GFP expression kinetics showed decreasing GFP intensity over time, but with localization remaining confined to MPs at later time points as well (Fig. S1B ). These data indicated that transcription of rAd-encoded genes occurred exclusively in MPs in the spleen, irrespective of the presence or absence of DCs.
Given that the metallophilic CD169 + MPs of the marginal zone are likely the first cells in the secondary lymphoid organs that get in touch with pathogens and their products, we asked whether they are susceptible to TLR ligands. On LPS injection, DCs increased the surface expression of CD80, CD86, and MHCII, whereas CD169 + MPs only up-regulated CD86 and MHCII, but not CD80. The overall levels of CD86 were at least fivefold lower on CD169
+ MPs compared with DCs (Fig. 1D ). Taken together, these data show that CD169 + MPs can modulate surface markers on TLR activation, with CD80 peculiarly excepted.
This ability to up-regulate MHC and costimulatory molecules, together with the fact that CD169 + MPs, but not DCs, selectively accumulate rAd vectors, suggests the possibility that CD169 , although it has a 1,000-fold higher binding affinity to K b (18) (19) (20) . The GP276 peptide binds D b with an intermediate affinity and triggers weaker responses, likely owing to low precursor frequencies (20) (21) (22) . As expected (2), CD11c-DTR mice did not mount any measurable CTL responses above background, indicating that DCs, MPs, or both are central to CTL priming. In contrast, Δ-DC mice generated CTLs specific for all three epitopes tested despite their lack of DCs ( Fig. 2A, Upper) . In vitro restimulation with the respective peptides showed that CTLs primed in Δ-DC and WT mice displayed comparable cytokine secretion capacities ( Fig. 2A, Lower) . These data suggest that rAd-encoded gene products are presented by cells other than DCs, most likely CD169 + MPs. To extend these analyses to other Ags, we used rAd vectors expressing cytosolic chicken ovalbumin (OVA), which harbors three peptides with immunodominance patterns correlated directly with their binding affinity to K epitopes can be primed in the absence of DCs as well. Considering that CD169 + MPs up-regulate costimulatory markers and are the only cells that also express Ag, they most likely prime these CTLs.
A caveat of the system is that Δ-DC mice have only one-half as many T cells as WT mice, so that numbers of specific CTLs were reduced by one-half. To correct for this, we adoptively transferred identical numbers of allogeneically marked D b /GP33-specific P14 or K b /OVA257-specific OTI TCR-transgenic T cells and analyzed their expansion on rAd-GP or rAd-OVA injection (Fig. 2C ). P14 and OT1 T cells expanded in Δ-DC mice as they did in WT recipients, whereas neither were activated in CD11c-DTR-mice (Fig. 2C) . These findings suggest that despite the absence of DCs, the presence of MPs and infection of CD169 + MPs (Fig. 1C) are sufficient for the priming of CTLs. In contrast, when both DCs and MPs were depleted in CD11c-DTR-mice, no CTL responses could be measured (Fig. 2C) . One potential reason for this failure in CD11c-DTR mice could be the lack of primary Ag handling by MPs of the marginal zone (Fig. 1B) ; however, histological analyses revealed that rAd-directed GFP expression was also present in spleens and lymph nodes of DTAtreated CD11c-DTR mice, but at different localizations than in organs of MP-sufficient mice (Fig. S1D) . GFP expression was detected in deeper zones of lymph nodes (Fig. S1D ) rather than being confined to few subcapsular CD169 + MPs as observed in WT nodes (Fig. S1 B and C) . In the spleens of CD11c-DTR mice, GFP expression was seen in only a few cells of the marginal zone, with the majority found in the red pulp area (Fig. S1D) . Therefore, although localized differently, rAd-encoded Ag was present in spleens and lymph nodes of DC-and MP-depleted CD11c-DTR-mice, but could not be presented for CTL priming. The fact that it worked in Δ-DC mice indicated that infection of MPs alone was sufficient for CTL responses.
DCs Selectively Cross-Prime CTLs Specific for Strong Epitopes Only.
Our results presented so far show that presence of infected MPs is sufficient to prime CTL responses in the absence of DCs. However, they do not reveal whether CTL priming by MPs and DCs is just redundant or qualitatively different. To determine whether the two APC types prime CTLs of different specificities, we used mice in which only DCs and thymic epithelial cells, and no other cell types, express MHCI molecules (26) . These animals generate a normal CD8 + T-cell repertoire that can be primed only by MHCI + DCs (27) . Using this model, we previously showed that DCs are sufficient to prime different virus-specific CTL responses (27) (28) (29) and to cross-present the model Ag OVA to OTI T cells (26) . Surprisingly, DC-MHCI mice injected with rAd-GP mounted nearly exclusively K b /GP33-specific CTL responses, with strongly reduced D b /GP33-specific responses and undetectable D b /GP276-specific responses (Fig. 3A) . A comparison of the distribution of CTL specificities as detected by MHC multimers in WT, Δ-DC, and DC-MHCI mice revealed that CTL responses induced in that absence of DCs (Δ-DC mice) or presence of DCs and MPs (WT mice) had a very similar composition (Fig. 3A) ; however, DCs alone (DC-MHCI) preferentially primed CTLs specific for the strongest of the three GP epitopes, K b /GP33, but were entirely unable to prime D b /GP33-specific CTLs (Fig. 3 A and B) . The K b /GP33-specific CTLs were fully functional, as demonstrated by their capacity to produce IFN-γ. In addition, after an increase in the precursor frequencies of specific CTLs by adoptive transfer of carboxyfluorescein succinimidyl ester (CFSE)-labeled D b /GP33-specific P14 T cells, no priming by DCs was detected in DC-MHCI recipients (Fig. 3C) .
The distribution of rAd-encoded proteins in DC-MHCI mice, as determined by histological analyses of rAd-GFP injection, matched the Ag distribution in WT mice (Fig. 1B) and was restricted to CD169
+ MPs of the marginal zone. From this, we concluded that the GP33 peptide was most likely transferred from CD169 + MPs to DCs for cross-presentation. Apparently, via this route the GP33 peptide is presented only by K b , to which it has a much higher affinity compared with D b . Our findings support the possibility that DCs cross-present only peptides of the highest affinity when Ag is acquired from MPs.
To put this hypothesis to a test, we analyzed CTL responses to rAd-OVA with its OVA257 peptide, which binds to K b with more than 10-fold higher affinity than OVA55 does (23) . We detected CTLs specific for both epitopes in WT mice, whereas DC-MHCI mice mounted only CTLs specific for K b /OVA257, and not those specific for K b /OVA55 ( Fig. 3D and Fig. S2 A and  B) . These experiments also revealed that rAd-OVA-immunized WT mice primed functional CTLs to the very weakly binding OVA107 peptide, which were not induced by cross-priming in DC-MHCI mice (Fig. 3D and Fig. S2B ).
Our data thus extend the evidence supporting the hypothesis that DCs present only high-affinity peptides from Ags handed over from MPs. This conclusion is based on the assumption that in DC-MHCI mice, the directly infected MPs are negative for MHCI and are unable to directly prime CTLs. Indeed, CD169 + MPs of DC-MHCI mice did express very low levels of MHCI, probably too low for CTL priming, whereas DCs of DC-MHCI mice expressed WT MHCI surface levels (Fig. 3E) . Taken together, our results indicate that the repertoires induced by crosspresenting DCs are very narrow and biased toward high-affinity peptides from Ags handed over from MPs; however, this gap in the repertoire is filled, and those CTLs spared by DCs are primed, when MPs accumulate Ags and express MHC class I (Fig. 3 A and D) .
To further analyze the Ag-presenting capacities of DCs, we isolated DCs from spleens of rAd-injected mice and tested them in vitro for their capacities to prime specific T cells. DCs from rAd-OVA-injected B6 and DC-MHCI mice could prime OVA257-specific CD8 + OTI T cells equally well, as when loaded with synthetic pOVA257 directly (Fig. 4A, Left) . In marked contrast, DCs from rAd-GP33-immunized mice did not stimulate P14 T cells in vitro even if the DCs originated from either strain, whereas peptide loading worked for both (Fig. 4A, Right) . These results suggest that DCs are able to cross-present K b /OVA257 following OVA acquisition from CD169
+ MPs, but not D b /GP33. A simple explanation for this finding is that DCs are not able to generate the complex at all or destroy it proteolytically. Therefore, we tested whether DCs can be infected in vitro with rAd-GFP, and detected a low but reproducible infection rate of ∼1% (Fig. 4B, Upper) . In addition, rAd-GP33-infected DCs could efficiently trigger proliferation of P14 T cells (Fig. 4B, Lower) . These results confirm our in vivo findings that DCs do not crosspresent the D b /GP33 epitope on rAd-GP33 injection ( Fig. 3 C and D), although they do so when provided as preprocessed peptide (Fig. 4A) or when infected directly with rAd-GP33 (Fig. 4B) .
To test whether infection or external loading of DCs would also lead to the priming of P14 T cells in vivo, we infected mice with LCMV, which infects spleen DCs directly (30) . Indeed, adoptively transferred P14 T cells were primed with similar efficiency in both B6 and DC-MHCI mice, corroborating our previous results (28) (Fig. 4C) . Moreover, when mice were immunized with GP33 and LPS, CFSE-labeled P14 T cells proliferated similarly in the two strains (Fig. 4D) . Taken together, these data suggest that DCs are able to prime D b /GP33-specific CTLs when directly infected, but not by cross-presentation from external sources. 
Discussion
The necessity for cross-presentation is based on the idea that DCs are the only professional APCs able to prime naïve T cells (1) . If Ag is not available to DCs directly, then DCs must take it up and present it indirectly. However, recent evidence suggests that other, as-yet unidentified cells might be involved in CD8 T-cell priming as well (11) . Such priming by other cells would possibly make cross-presentation by DCs less important. Our findings support this view. We demonstrate that CTL repertoires induced by cross-priming DCs have only very restricted specificities only for a few strong epitopes. Normal CTL responses can be mounted despite a complete lack of DCs. When MHCI + CD169 + MPs of the marginal zone do capture Ag, CTLs specific for all epitopes tested can be primed, as well as those spared out by cross-presenting DCs. Therefore, we identified CD169 + MPs as important, nonredundant APCs of similar significance as DCs. In summary, although infection of CD169 + MPs leads to generation of CTLs specific for all epitopes tested for, cross-presenting DCs additionally strengthen only a few CTL specificities from a broad repertoire.
Owing to its deficiency for DCs, the Δ-DC mouse model is a valuable tool for analyzing the contribution of MPs to CTL priming, given the impossibility of isolating viable marginal zone MPs for functional T-cell stimulation assays in vitro (12) . MPs in general have received much attention recently. Initially considered scavenger cells and pathogen filters, they were thought to have little or no T-cell priming capability; however, they were found to modulate immunity via cytokine production and recruitment. Their Ag-handling capacities remained restricted to Ag redistribution to DCs and B cells. Although it is not possible to isolate marginal zone MPs for a direct demonstration of their APC capacities in vitro, our findings indirectly support the notion that they also might be able to prime CTLs directly, for several reasons. First, we found that virus-encoded Ag colocalizes selectively in CD169
+ MPs. Although Ag detection by microscopy most likely is not sensitive enough to exclude the presence of low levels of DC infection, this is insufficient for priming of CTLs specific for weaker epitopes, such as P14 T cells. Second, in theory CD169 + MP-borne Ag also could reach other cells via the exogenous crosspresentation route, as reported previously for CD8 + DCs (9); however, DCs are generally considered the most potent crosspresenting APCs in vivo (4, 31) and a cross-presenting non-DC able to more potently prime CTLs also specific for weak epitopes is currently unknown. Third, we show that exclusive cross-presentation by DCs generates CTL-responses specific for just two of the six epitopes studied, whereas in Δ-DC mice the presence of infected MPs is sufficient for priming of CTLs to all epitopes derived from OVA and LCMV-GP. Taken together, our results support the interpretation that CD169 + MPs are sufficient to prime CTLs also specific for weaker epitopes. CD169 + MPs are rather sessile in the spleen marginal zone or subcapsular sinus of lymph nodes; therefore, it is conceivable that CD8 + T-cell priming by MPs requires T-cell migration to the marginal zone or lymph node sinus areas. Although such interactions have been observed during memory responses in vivo (32) , whether interactions with naïve CD8 + T cells may also occur there is unclear. Blood-borne Ag is first trapped by CD169 + marginal zone MPs, making a role for CD169 + MPs in early CTLpriming events rather likely. Thereafter, additional cross-priming may occur once Ag reaches CD8 + DCs in T-cell areas. Previous studies showed that APC functions of CD169 + MPs are limited to the immunodominant epitope K b /OVA257 (12, 32) , which also can be cross-presented efficiently, but redundantly, by DCs. In contrast, we demonstrate that CD169 + MPs also prime CTLs specific for weaker epitopes that cannot be cross-primed by DCs. Such a division of labor might occur selectively in situations where DCs either are not directly infected or do not receive sufficient amounts of Ag necessary for cross-presentation (33) . This is the case with the rAd vectors used in the present study, but might be different for other infectious agents that preferentially target DCs. 
